Leticia C. H.
- Country
- Spain
- Department
- Servicio de Pediatría, Unidad de Enfermedades Raras Metabólicas
Research Overview
Data & Insights
Has run more than one trial at 0 of 3 partner sites.
Specializations
Metabolic Disorders
Specialized focus on investigating therapeutic approaches for Ornithine Transcarbamylase (OTC) deficiency, particularly in its late-onset manifestation in adult patients.
- Urea Cycle Disorders
- Genetic Metabolic Conditions
- Adult-Onset Enzyme Deficiencies
Active involvement in evaluating innovative gene therapy approaches for metabolic disorders, with particular attention to long-term therapeutic outcomes in adult populations.
Gene Therapy Applications
Expertise in studying viral vector-mediated gene transfer techniques, specifically focused on therapeutic applications for enzyme deficiency disorders.
- Gene Transfer Technologies
- Enzyme Replacement Strategies
- Long-term Safety Assessment
Investigates the therapeutic potential of genetic interventions in addressing inherited metabolic disorders through targeted delivery systems.
Clinical Development
Focused on evaluating novel therapeutic interventions for rare genetic disorders, with emphasis on safety monitoring and long-term patient outcomes.
- Rare Disease Treatment
- Safety Profile Assessment
- Long-term Patient Monitoring
Dedicated to advancing treatment options for patients with inherited metabolic disorders through innovative therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.